Larvol Delta - Entos-Pharmaceuticals-Announces-Selection-of-Lead-DNA-Vaccine-Candidates-for-COVID19-and-a-42M-Award-to-Move-Forward-with-Phase-III-Human-Trials

Covigenix vaccine candidate 1 - Entos Pharma, EpiVax

https://pipelinereview.com/index.php/2020062675141/Vaccines/Entos-Pharmaceuticals-Announces-Selection-of-Lead-DNA-Vaccine-Candidates-for-COVID-19-and-a-$4.2M-Award-to-Move-Forward-with-Phase-I/II-Human-Trials.html

Jun 26, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev